Skip to main content
GOSS logo

GOSS · Gossamer Bio, Inc. · Webcasts, Transcripts & Audio

Track GOSS — free
$11.50 +0.07 (+0.61%) Play latest call Q2 2026 earnings call transcript
Market Cap
$68.69M
Shares
6.12M
Volume · Nov 19 143.82K Avg daily vol (50 sessions) 251.05K

Gossamer Bio, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Gossamer Bio, Inc. (GOSS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-07-27
Gossamer Bio, Inc. (GOSS) Q2 2026 Earnings Call Transcript
Confident tone Saralutinib clinical evidence FDA regulatory path and NDA submission PHILD indication expansion
Revenue
$9.24M
▼ 19.6% YoY
Diluted EPS
$-6.40
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-18
Gossamer Bio, Inc. (GOSS) Q1 2026 Earnings Call Transcript
Positive tone CT-FRI sub-study and reverse remodeling Procera Phase III results and clinical signal Unmet need in PAH and community support
Revenue
$16.95M
▲ 71.5% YoY
Diluted EPS
$-16.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
Gossamer Bio, Inc. (GOSS) Q1 2025 Earnings Call Transcript
Confident tone Seralutinib commercial opportunity PROSERA Phase III enrollment Competitive landscape (sotatercept, Tyvaso)
Revenue
$9.89M
Diluted EPS
$-12.80
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Gossamer Bio, Inc. (GOSS) Q2 2023 Earnings Call
Revenue
$0
Diluted EPS
$-36.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Gossamer Bio, Inc. (GOSS) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Gossamer Bio, Inc. (GOSS) Q3 2021 Earnings Call Transcript
Diluted EPS
$-64.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Gossamer Bio, Inc. (GOSS) Q2 2021 Earnings Call Transcript
Diluted EPS
$-64.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Gossamer Bio, Inc. (GOSS) Q1 2021 Earnings Call
Diluted EPS
$-62.40
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Gossamer Bio, Inc. (GOSS) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Gossamer Bio, Inc. (GOSS) Q3 2020 Earnings Call Transcript
Diluted EPS
$-64.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
Gossamer Bio, Inc. (GOSS) Q1 2020 Earnings Call Transcript
Diluted EPS
$-69.60
Audio Transcript Slides 8-K10-Q
Showing 1–11 of 11 webcasts
Key facts CIK 1728117 CUSIP 38341P201 13F (30d) 100 filings 75 filers Visit website Investor relations